Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Qlucore Announces Aid to Better Visualizations of Large Data Sets

Published: Tuesday, December 10, 2013
Last Updated: Tuesday, December 10, 2013
Bookmark and Share
New traffic-light Qlucore Projection Score indicates the usefulness of a Principal Component Analysis (PCA) representation.

Historically, scientists and researchers have been faced with a problem when looking at visualizations of large amounts of data, of whether the patterns they are seeing are statistically valid, or random.

Qlucore Projection Score is a unique functionality that will be available in the new version of Qlucore Omics Explorer 3.0. Projection Score will provide the user with information on how accurately the visual representation is actually portraying data.

The patent-pending Qlucore Projection Score technique is the brain child of Qlucore co-founder Magnus Fontes. It allows detailed comparison of representations obtained by PCA corresponding to different variable subsets, e.g., those obtained by variance filtering of a large data set.

The goal of exploratory visualization is to find a representation from which interpretable and potentially interesting information can be extracted, that is, one that contains structures and patterns that are likely to be non-random.

By following the evolution of the projection score in real time during variance filtering, the user can easily find the variable subset (and thus implicitly the variance cut-off) giving the most informative representation.

Magnus Fontes, the co-founder of Qlucore and developer of the Projection Score concept comments: "Qlucore is proud to be at the forefront of visualization technology for scientific research. The Projection Score technique is one which I have been working on for a considerable time and it will be very valuable in aiding research scientists to validate their data visualization work. The technique has been welcomed by my peers and I am delighted that it is now available on a commercial basis."

To compute the projection score for a given data set, the user must start by computing the fraction of the total variance that is captured by the first three principal components. Then, an estimate is taken for the expected value of the same entity for completely random data.

The projection score is defined as the difference between the square root of the observed quantity and the square root of the expected value for random data. Hence, a large value of the projection score means that the PCA representation of the observed representation contains much more information (variance) than the corresponding representation of a random data set of the same size, which suggests that there are non-random, potentially interesting structures present in the representation.

In contrast, a projection score close to zero indicates that the representation is not more informative than one of a random data set and that there are no broad, consistent patterns to be found by the PCA.

By monitoring the evolution of the projection score during variance filtering, the optimal variable subset can be found. In Qlucore Omics Explorer 3.0 the projection score is colored according to the displayed value. Red indicates a low projection score, yellow indicates a medium-high score and green corresponds to a high projection score.

In practice, almost all real data sets contain some non-random structure, and therefore it is very uncommon to get a projection score close to zero. The colours, and thus the boundaries between what is considered to be a "good" or a "bad" projection score, are based on our experience from applying the projection score to many different data sets, and should be interpreted mainly as rough guidelines suggesting the quality of the representations.

The projection score is a widely versatile technique that is applicable for a broad family of different statistical analyses. The statistical and technical details have been published by Magnus Fontes and Charlotte Soneson in the prestigous scientific journal BMC Bioinformatics in 2011.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Revealing Human-growth Patterns in Transcriptomic Data
Understanding how children grow is key to understanding many childhood diseases and conditions, particularly those affecting growth.
Monday, May 19, 2014
Fighting to Reduce Dependence on Chemical Fungicides
The research is focused on how plants defend themselves against oomycetes and fungi.
Wednesday, February 19, 2014
Qlucore, Nebion Collaborate
Partnership aims to address complementary use cases.
Friday, February 07, 2014
Using Qlucore Omics Explorer for Interpreting Leukemia Proteomics Data
Qlucore software has speeded up the process and enabled discovery for leukemia researcher Steven Kornblau.
Monday, November 18, 2013
Qlucore Receives European Funding That will Benefit Personalized Medicine
Hepatitis C patients to benefit from European funding awarded to Qlucore.
Thursday, September 05, 2013
New Research Aims to Stop ‘Blood Doping' During Cycling and Other Competitive Sports
As cyclists take to the roads of Surrey, England, the subject of blood doping raises its head once again.
Thursday, August 01, 2013
How it Works: Advanced Data Analysis Using Visualisation
Visualisation is a powerful tool for those working in molecular biology, here Qlucore offers a five-step method to ensure repeatable and significant results.
Monday, June 24, 2013
Qlucore Receives R&D Funding
VINNOVA Grant will speed the interactivity and visual feedback of Next Generation Sequencing (NGS) data analysis for scientists.
Monday, April 29, 2013
Researchers Develop Animal Free Methods for Testing Chemical Compounds for Allergens
EU-funded research project developing in vitro (‘out of body’) test strategies to reduce or replace animal testing use gene expression analysis software.
Monday, April 08, 2013
Qlucore Targets Academic and Commercial Biotech, Life Science Markets with Novo Newton Scientific Ltd
New alliance increases Qlucore's sales and marketing presence in Ireland, Spain, Italy and South Africa.
Thursday, January 24, 2013
Visualising Complex Data Results from 100,000 Cancer Patients
For decades, biomedical scientists have tried to develop a diagnostic tool for the early stages of cancer.
Wednesday, December 12, 2012
New Biomarkers Could Offer Vital Clues for Cancer Research
European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore.
Friday, May 04, 2012
Unlocking the Secrets of Complex Genetic Data
A new approach to data analysis is helping researchers at Cincinnati Children's Hospital Medical Center to unravel the mysteries of human disease, says Carl-Johan Ivarsson, President of Qlucore.
Monday, March 19, 2012
New Research Techniques Could Help to Eliminate the Need for Animal Testing
Carl-Johan Ivarsson, Qlucore, comments on the reducing necessity for animal models in today’s drug development industry, as research moves more towards in vitro analysis.
Monday, March 19, 2012
NHS Urged to Prepare for ‘Genetic Revolution’
The ability to bring biologists into the data analysis phase will be key to achieving this important goal.
Monday, November 21, 2011
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!